| |
| Treatment of primary progressive multiple sclerosis (PPMS) is
problematic as many patients do not respond to any available
therapy, and no treatment has been approved specifically for use in
this form of the disease. Several trials have been designed
specifically for PPMS, including trials with interferons and
mitoxantrone, a phase III trial of glatiramer acetate, and an
open-label study of riluzole. Patients with PPMS have also been
included in trials of azathioprine, methotrexate.
|
| |
|
|
| |
|
Treatment of advanced forms of MS is more difficult than relapsing-remitting MS. A wide range of medications have been used to try to slow the progression of the disease, with results that have been at best fair.
Mitoxantrone has shown positive effects in patients with a secondary progressive and progressive relapsing courses. It is moderately effective in reducing the progression of the disease and the frequency of relapses in patients in short-term follow-up. In 2007 it was the only medication approved in the USA for both secondary progressive and progressive relapsing multiple sclerosis; however, it causes dose-dependent cardiac toxicity which limits its long-term use. It is also not approved in Europe.
There is copiousness obtainable on the Internet, but what you don't know is that you are the one to make it easy. First of all you have to ask yourself about the reasons for which you want to lose weight. Is it for you, to be recovered and have better looks? Or are you doing it for a big shot else?
|
Recommended Sites.....
|
|
